Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
RNA binding (GO:0003723),91/1406,8.453840762274667e-57,2.105006349806392e-54,0,0,14.552765295540961,1878.9472481266453,RPL4;RPL5;RPL30;RPL3;HSP90AB1;DDX3X;RPL32;RPL31;RPL34;RPLP0;GDI2;MSI2;RPL10A;MKI67;RPL9;RPL6;RPL7;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPS18;RACK1;MYO18A;RPL38;RPL37;RPS11;RPL39;RPS13;RPS12;DDX17;HSP90AA1;RPL21;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPSA;RPS3A;YWHAZ;HNRNPH1;RPL37A;SRSF3;RPL24;MYH9;RPL27;RPL29;SLC25A5;MACF1;DDX5;RPL10;PRKDC;KMT2C;RPL12;RPL11;BAZ2A;PRPF8;ZFP36L2;HSPD1;TRA2B;RPS3;RPL14;RPL13;RPS2;RPS27A;RPL19;BTF3;HSPA8;RBM39;DYNC1H1;NPM1;HUWE1;PRRC2C;RPL35A;RPL23A;EEF2;RPS26;RPS25;RPS27;SON;EIF3L;RPL27A;HNRNPA2B1;RPS20;RPS24;EIF4G2;TPT1;RPS23
cadherin binding (GO:0045296),20/322,1.1720059136227573e-11,1.0817635279533788e-9,0,0,8.129867966179349,204.6264945412967,MACF1;HSPA8;HSP90AB1;DDX3X;RPL34;RPL23A;EEF2;YWHAZ;RPL6;RPS26;PDLIM1;RPL7A;RACK1;RPL14;RPL24;MYH9;RPS2;RPL29;WASF2;EIF4G2
ubiquitin ligase inhibitor activity (GO:1990948),6/8,1.3033295517510588e-11,1.0817635279533788e-9,0,0,343.6820809248555,8613.880591503696,RPL5;RPS7;RPL23;RPL11;RPS20;RPL37
ubiquitin-protein transferase inhibitor activity (GO:0055105),6/9,3.8810950822316964e-11,2.415981688689231e-9,0,0,229.10982658959537,5492.293773762374,RPL5;RPS7;RPL23;RPL11;RPS20;RPL37
rRNA binding (GO:0019843),9/42,1.0411133123942045e-10,5.184744295723138e-9,0,0,31.745454545454546,729.6870595997153,RPL5;RPS14;RPL12;RPL23;RPS5;RPL11;RPLP0;RPS3;RPS13
mRNA binding (GO:0003729),16/263,1.9939927963541644e-9,8.275070104869782e-8,0,0,7.778843049104593,155.8345489894535,RPL5;DDX5;DDX3X;RPS7;RPS5;RPL13A;RPS3A;RPL7;RPS26;RPS14;TRA2B;HNRNPA2B1;RPS3;RPS2;RPS13;EIF4G2
mRNA 5'-UTR binding (GO:0048027),6/25,7.265919726935595e-8,2.584591445724233e-6,0,0,36.146029814420444,594.1498538966567,RPL5;RPS14;DDX3X;RPS7;RPS3A;RPS13
large ribosomal subunit rRNA binding (GO:0070180),3/5,6.957299430972609e-6,2.1654594478902247e-4,0,0,168.9119318181818,2005.9506670230244,RPL12;RPL23;RPLP0
ubiquitin protein ligase binding (GO:0031625),11/265,2.796836352039378e-5,7.737913907308946e-4,0,0,5.043986689163854,52.883358456309594,RPL5;HSPA8;HSP90AA1;HSP90AB1;RPL23;RPL11;SLC25A5;RPS27A;UBA52;YWHAZ;HSPD1
disordered domain specific binding (GO:0097718),4/23,4.809437610499539e-5,0.001114949097884359,0,0,23.821954887218045,236.84610141419404,HSP90AA1;HSP90AB1;NUMA1;CALM1
ubiquitin-like protein ligase binding (GO:0044389),11/282,4.925477942461024e-5,0.001114949097884359,0,0,4.723466877525918,46.84972583138011,RPL5;HSPA8;HSP90AA1;HSP90AB1;RPL23;RPL11;SLC25A5;RPS27A;UBA52;YWHAZ;HSPD1
small ribosomal subunit rRNA binding (GO:0070181),3/9,5.691679652184023e-5,0.0011810235278281846,0,0,56.29261363636363,550.199506026748,RPS14;RPS3;RPS13
kinase binding (GO:0019900),13/461,2.7233754722385335e-4,0.005216311481441499,0,0,3.386523773666093,27.798172970896374,PFKFB2;NPM1;HSP90AB1;GSN;RPS7;RPS6;PTPRK;EEF2;YWHAZ;CDC42;RPS19;RPS3;CALM1
MHC class II protein complex binding (GO:0023026),3/17,4.370752226642833e-4,0.007773695031671896,0,0,24.115665584415584,186.54444601070665,HSPA8;HSP90AA1;HSP90AB1
protein kinase binding (GO:0019901),13/506,6.55699678151308e-4,0.010803196331318798,0,0,3.070260759060583,22.504420896100154,PFKFB2;HSP90AA1;NPM1;RPS7;RPS6;PTPRK;EEF2;YWHAZ;CDC42;RPS19;RACK1;RPS3;CALM1
ATP hydrolysis activity (GO:0140603),4/45,6.941812903658665e-4,0.010803196331318798,0,0,11.027177700348432,80.19820883390612,HSP90AA1;DDX3X;RNF213;MYO18A
TPR domain binding (GO:0030911),2/5,7.825622025090394e-4,0.011462234613220636,0,0,74.64406779661017,533.9243253220434,HSP90AA1;HSP90AB1
mRNA 3'-UTR binding (GO:0003730),5/85,9.99151591782653e-4,0.013821597019660034,0,0,7.090876436781609,48.98805765006373,RPL5;DDX5;RPS7;HNRNPA2B1;ZFP36L2
ADP binding (GO:0043531),3/27,0.0017604877931649211,0.02307165581568765,0,0,14.060369318181818,89.17317308154722,MYO18A;PGK1;MYH9
pre-mRNA binding (GO:0036002),3/29,0.002170610401299741,0.027024099496181776,0,0,12.977491258741258,79.58766876854182,DDX5;TRA2B;PRPF8
5S rRNA binding (GO:0008097),2/9,0.002751545414793024,0.03262546706111728,0,0,31.983857949959646,188.56379484621226,RPL5;RPL11
nucleoside-triphosphatase activity (GO:0017111),8/278,0.003645990484308419,0.04126598320876347,0,0,3.387654320987654,19.018722310433702,CDC42;HSP90AA1;RNF213;DDX3X;GNAS;MYO18A;MYH9;EEF2
calcium channel inhibitor activity (GO:0019855),2/11,0.004154557768801633,0.04497760367093942,0,0,24.87382297551789,136.39683431302154,ITPR1;CALM1
ion channel inhibitor activity (GO:0008200),3/37,0.004380336525286229,0.045445991449844625,0,0,9.91995320855615,53.871592767852086,ITPR1;RACK1;CALM1
microtubule minus-end binding (GO:0051011),2/13,0.005823066766900985,0.056056616697988934,0,0,20.3492552645095,104.71580692420976,MACF1;NUMA1
DNA binding (GO:0003677),15/811,0.006354685407521997,0.056056616697988934,0,0,2.186044552028435,11.058243822096633,DDX3X;H2AC6;PRKDC;HUWE1;ARID5B;SMARCA2;RPL6;RPL7;HSPD1;NR4A1;RPS27;IRF4;RPS3;TCF4;HMGN1
adenyl ribonucleotide binding (GO:0032559),8/306,0.006433199881123714,0.056056616697988934,0,0,3.064955453510734,15.466633262291312,HSPA8;HSP90AA1;HSP90AB1;INSR;PGK1;MYO18A;PDE4B;MYH9
protein kinase inhibitor activity (GO:0004860),3/43,0.006690261186365941,0.056056616697988934,0,0,8.42940340909091,42.2068857392452,NPM1;RACK1;SH3BP5
insulin-like growth factor receptor binding (GO:0005159),2/14,0.006753809240721558,0.056056616697988934,0,0,18.652542372881356,93.21885230078709,INSR;GNAS
translation elongation factor activity (GO:0003746),2/14,0.006753809240721558,0.056056616697988934,0,0,18.652542372881356,93.21885230078709,EEF1B2;EEF2
transmembrane receptor protein phosphatase activity (GO:0019198),2/16,0.008802267339674898,0.06848515975734908,0,0,15.986279257465698,75.65899822667954,PTPRE;PTPRK
transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),2/16,0.008802267339674898,0.06848515975734908,0,0,15.986279257465698,75.65899822667954,PTPRE;PTPRK
ribosome binding (GO:0043022),3/48,0.00907634647386554,0.06848515975734908,0,0,7.490909090909091,35.22288032147819,RACK1;RPSA;EEF2
ribosomal small subunit binding (GO:0043024),2/17,0.009917630202507998,0.070556854869271185,0,0,14.919774011299435,68.83150126874065,NPM1;DDX3X
adrenergic receptor binding (GO:0031690),2/17,0.009917630202507998,0.070556854869271185,0,0,14.919774011299435,68.83150126874065,GRK2;GNAS
guanyl-nucleotide exchange factor activity (GO:0005085),5/149,0.01104021900220776,0.07464755426254283,0,0,3.9266044061302683,17.694105616197678,EEF1B2;PREX1;AKAP13;HPS4;SH3BP5
DNA polymerase binding (GO:0070182),2/18,0.011092206858289495,0.07464755426254283,0,0,13.986581920903955,62.960773378309824,HSP90AA1;HSP90AB1
R-SMAD binding (GO:0070412),2/19,0.012324860283012329,0.08076026869658079,0,0,13.163177135260884,57.86712866213049,DDX5;LDLRAD4
ATP binding (GO:0005524),7/278,0.012778514946958712,0.08158590312289024,0,0,2.9359392431133613,12.800665852494191,HSPA8;HSP90AA1;HSP90AB1;INSR;PGK1;MYO18A;MYH9
fibroblast growth factor binding (GO:0017134),2/21,0.014959926202755396,0.09312554061215234,0,0,11.776390127862028,49.48886916501484,RPS19;RPS2
K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),2/22,0.016360140971545267,0.09935792931499443,0,0,11.187005649717515,46.01111754868441,TNFAIP3;PRPF8
protein kinase activator activity (GO:0030295),3/63,0.018909645520071013,0.11210718415470673,0,0,5.613920454545455,22.276503116889778,DDX3X;RPLP1;CALM1
actin binding (GO:0003779),5/177,0.021668942384544258,0.12547829427329116,0,0,3.282711841753542,12.578942325402565,PDLIM1;MACF1;GSN;MYH9;SYNE2
nuclear receptor binding (GO:0016922),4/120,0.022853031994268608,0.12932738560392917,0,0,3.882758620689655,14.671669260731958,NR4A1;DDX5;JMJD1C;BAZ2A
double-stranded RNA binding (GO:0003725),3/73,0.027769428707809858,0.1536575055165479,0,0,4.809496753246753,17.236368490688502,DDX3X;HSP90AB1;HSPD1
SH2 domain binding (GO:0042169),2/32,0.033144259932899836,0.17103268025392576,0,0,7.454237288135594,25.395734657694085,RACK1;PAG1
kinase inhibitor activity (GO:0019210),2/33,0.03507890690950242,0.17103268025392576,0,0,7.213413522872243,24.166055342030788,NPM1;SH3BP5
calcium channel regulator activity (GO:0005246),2/37,0.043236166661996527,0.17103268025392576,0,0,6.38773204196933,20.064364221107684,ITPR1;CALM1
core promoter sequence-specific DNA binding (GO:0001046),2/37,0.043236166661996527,0.17103268025392576,0,0,6.38773204196933,20.064364221107684,NPM1;BAZ2A
protein serine/threonine kinase activator activity (GO:0043539),2/37,0.043236166661996527,0.17103268025392576,0,0,6.38773204196933,20.064364221107684,DDX3X;CALM1
RNA polymerase II general transcription initiation factor binding (GO:0001091),1/5,0.043960206972896584,0.17103268025392576,0,0,27.832865168539325,86.9629645143461,TCF4
RNA strand annealing activity (GO:0033592),1/5,0.043960206972896584,0.17103268025392576,0,0,27.832865168539325,86.9629645143461,DDX3X
sequence-specific single stranded DNA binding (GO:0098847),1/5,0.043960206972896584,0.17103268025392576,0,0,27.832865168539325,86.9629645143461,HNRNPA2B1
alpha-2A adrenergic receptor binding (GO:0031694),1/5,0.043960206972896584,0.17103268025392576,0,0,27.832865168539325,86.9629645143461,GRK2
annealing activity (GO:0097617),1/5,0.043960206972896584,0.17103268025392576,0,0,27.832865168539325,86.9629645143461,DDX3X
apolipoprotein A-I binding (GO:0034186),1/5,0.043960206972896584,0.17103268025392576,0,0,27.832865168539325,86.9629645143461,HSPD1
beta-2 adrenergic receptor binding (GO:0031698),1/5,0.043960206972896584,0.17103268025392576,0,0,27.832865168539325,86.9629645143461,GNAS
U2 snRNA binding (GO:0030620),1/5,0.043960206972896584,0.17103268025392576,0,0,27.832865168539325,86.9629645143461,PRPF8
opioid receptor binding (GO:0031628),1/5,0.043960206972896584,0.17103268025392576,0,0,27.832865168539325,86.9629645143461,GNAS
"oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor (GO:0016668)",1/5,0.043960206972896584,0.17103268025392576,0,0,27.832865168539325,86.9629645143461,PGK1
cytoskeleton-nuclear membrane anchor activity (GO:0140444),1/5,0.043960206972896584,0.17103268025392576,0,0,27.832865168539325,86.9629645143461,SYNE2
"fructose-2,6-bisphosphate 2-phosphatase activity (GO:0004331)",1/5,0.043960206972896584,0.17103268025392576,0,0,27.832865168539325,86.9629645143461,PFKFB2
protein tyrosine kinase inhibitor activity (GO:0030292),1/5,0.043960206972896584,0.17103268025392576,0,0,27.832865168539325,86.9629645143461,RACK1
purine nucleotide transmembrane transporter activity (GO:0015216),1/5,0.043960206972896584,0.17103268025392576,0,0,27.832865168539325,86.9629645143461,SLC25A5
tau protein binding (GO:0048156),2/40,0.049768906381139504,0.17436268723761214,0,0,5.882545346416889,17.649782343617474,HSP90AA1;HSP90AB1
translation initiation factor activity (GO:0003743),2/41,0.05202091700987645,0.17436268723761214,0,0,5.73142112125163,16.942707800833247,EIF3L;EIF4G2
supercoiled DNA binding (GO:0097100),1/6,0.05251888169807595,0.17436268723761214,0,0,22.265168539325842,65.6061564818719,RPS3
apolipoprotein receptor binding (GO:0034190),1/6,0.05251888169807595,0.17436268723761214,0,0,22.265168539325842,65.6061564818719,CDC42
BH domain binding (GO:0051400),1/6,0.05251888169807595,0.17436268723761214,0,0,22.265168539325842,65.6061564818719,RACK1
BH3 domain binding (GO:0051434),1/6,0.05251888169807595,0.17436268723761214,0,0,22.265168539325842,65.6061564818719,RACK1
C3HC4-type RING finger domain binding (GO:0055131),1/6,0.05251888169807595,0.17436268723761214,0,0,22.265168539325842,65.6061564818719,HSPA8
dopamine receptor binding (GO:0050780),1/6,0.05251888169807595,0.17436268723761214,0,0,22.265168539325842,65.6061564818719,GNAS
primary miRNA binding (GO:0070878),1/6,0.05251888169807595,0.17436268723761214,0,0,22.265168539325842,65.6061564818719,DDX5
purine nucleobase transmembrane transporter activity (GO:0005345),1/6,0.05251888169807595,0.17436268723761214,0,0,22.265168539325842,65.6061564818719,SLC25A5
high-density lipoprotein particle binding (GO:0008035),1/6,0.05251888169807595,0.17436268723761214,0,0,22.265168539325842,65.6061564818719,HSPD1
purine ribonucleoside triphosphate binding (GO:0035639),8/460,0.055409844286275454,0.18154014772740246,0,0,2.0047611654504993,5.799770054789276,CDC42;HSPA8;HSP90AA1;HSP90AB1;INSR;PGK1;MYO18A;MYH9
protein kinase regulator activity (GO:0019887),3/98,0.057886838765637,0.18300409031205864,0,0,3.539354066985646,10.084558479682945,NPM1;RPLP1;SH3BP5
insulin-like growth factor II binding (GO:0031995),1/7,0.06100136343735288,0.18300409031205864,0,0,18.553370786516854,51.89116324509466,INSR
ADP transmembrane transporter activity (GO:0015217),1/7,0.06100136343735288,0.18300409031205864,0,0,18.553370786516854,51.89116324509466,SLC25A5
sugar-phosphatase activity (GO:0050308),1/7,0.06100136343735288,0.18300409031205864,0,0,18.553370786516854,51.89116324509466,PFKFB2
N6-methyladenosine-containing RNA binding (GO:1990247),1/7,0.06100136343735288,0.18300409031205864,0,0,18.553370786516854,51.89116324509466,HNRNPA2B1
organic acid:sodium symporter activity (GO:0005343),1/7,0.06100136343735288,0.18300409031205864,0,0,18.553370786516854,51.89116324509466,SLC38A1
phosphofructokinase activity (GO:0008443),1/7,0.06100136343735288,0.18300409031205864,0,0,18.553370786516854,51.89116324509466,PFKFB2
RNA polymerase I core promoter sequence-specific DNA binding (GO:0001164),1/8,0.06940832625547197,0.1920297026401391,0,0,15.902086677367576,42.422766986769005,BAZ2A
RNA polymerase I transcription regulatory region sequence-specific DNA binding (GO:0001163),1/8,0.06940832625547197,0.1920297026401391,0,0,15.902086677367576,42.422766986769005,BAZ2A
L-glutamine transmembrane transporter activity (GO:0015186),1/8,0.06940832625547197,0.1920297026401391,0,0,15.902086677367576,42.422766986769005,SLC38A1
U1 snRNA binding (GO:0030619),1/8,0.06940832625547197,0.1920297026401391,0,0,15.902086677367576,42.422766986769005,PRPF8
oxidized DNA binding (GO:0032356),1/8,0.06940832625547197,0.1920297026401391,0,0,15.902086677367576,42.422766986769005,RPS3
DNA N-glycosylase activity (GO:0019104),1/8,0.06940832625547197,0.1920297026401391,0,0,15.902086677367576,42.422766986769005,RPS3
pre-mRNA intronic binding (GO:0097157),1/8,0.06940832625547197,0.1920297026401391,0,0,15.902086677367576,42.422766986769005,PRPF8
polyubiquitin modification-dependent protein binding (GO:0031593),2/51,0.07638116523479245,0.20814375439125152,0,0,4.559437334255736,11.72696009837237,TNFAIP3;PRPF8
U3 snoRNA binding (GO:0034511),1/9,0.07774043838709395,0.20814375439125152,0,0,13.913623595505618,35.54067786656654,PRKDC
glucocorticoid receptor binding (GO:0035259),1/9,0.07774043838709395,0.20814375439125152,0,0,13.913623595505618,35.54067786656654,NR4A1
adenylate cyclase binding (GO:0008179),1/10,0.0859983623481033,0.20938844598353806,0,0,12.367041198501873,30.34163310031636,CALM1
ionotropic glutamate receptor binding (GO:0035255),1/10,0.0859983623481033,0.20938844598353806,0,0,12.367041198501873,30.34163310031636,GNAS
Tat protein binding (GO:0030957),1/10,0.0859983623481033,0.20938844598353806,0,0,12.367041198501873,30.34163310031636,NPM1
Lys63-specific deubiquitinase activity (GO:0061578),1/10,0.0859983623481033,0.20938844598353806,0,0,12.367041198501873,30.34163310031636,TNFAIP3
ATP transmembrane transporter activity (GO:0005347),1/10,0.0859983623481033,0.20938844598353806,0,0,12.367041198501873,30.34163310031636,SLC25A5
co-SMAD binding (GO:0070410),1/10,0.0859983623481033,0.20938844598353806,0,0,12.367041198501873,30.34163310031636,USP9X
oxidized purine DNA binding (GO:0032357),1/10,0.0859983623481033,0.20938844598353806,0,0,12.367041198501873,30.34163310031636,RPS3
eukaryotic initiation factor 4E binding (GO:0008190),1/10,0.0859983623481033,0.20938844598353806,0,0,12.367041198501873,30.34163310031636,DDX3X
G-rich strand telomeric DNA binding (GO:0098505),1/10,0.0859983623481033,0.20938844598353806,0,0,12.367041198501873,30.34163310031636,HNRNPA2B1
histone methyltransferase binding (GO:1990226),1/11,0.09418275481990468,0.20938844598353806,0,0,11.129775280898876,26.29429648508577,HSP90AB1
hyaluronic acid binding (GO:0005540),1/11,0.09418275481990468,0.20938844598353806,0,0,11.129775280898876,26.29429648508577,CD44
"inositol 1,4,5 trisphosphate binding (GO:0070679)",1/11,0.09418275481990468,0.20938844598353806,0,0,11.129775280898876,26.29429648508577,ITPR1
intracellular ligand-gated ion channel activity (GO:0005217),1/11,0.09418275481990468,0.20938844598353806,0,0,11.129775280898876,26.29429648508577,ITPR1
amino acid:sodium symporter activity (GO:0005283),1/11,0.09418275481990468,0.20938844598353806,0,0,11.129775280898876,26.29429648508577,SLC38A1
thioesterase binding (GO:0031996),1/11,0.09418275481990468,0.20938844598353806,0,0,11.129775280898876,26.29429648508577,CDC42
MAP-kinase scaffold activity (GO:0005078),1/11,0.09418275481990468,0.20938844598353806,0,0,11.129775280898876,26.29429648508577,AKAP13
myosin II binding (GO:0045159),1/11,0.09418275481990468,0.20938844598353806,0,0,11.129775280898876,26.29429648508577,GSN
death domain binding (GO:0070513),1/11,0.09418275481990468,0.20938844598353806,0,0,11.129775280898876,26.29429648508577,RACK1
DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),1/11,0.09418275481990468,0.20938844598353806,0,0,11.129775280898876,26.29429648508577,RPS3
ribosomal large subunit binding (GO:0043023),1/12,0.10229426679107169,0.2158582409404818,0,0,10.117466802860061,23.06682926467287,NPM1
"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",1/12,0.10229426679107169,0.2158582409404818,0,0,10.117466802860061,23.06682926467287,PDE4B
RNA stem-loop binding (GO:0035613),1/12,0.10229426679107169,0.2158582409404818,0,0,10.117466802860061,23.06682926467287,DDX3X
adenine nucleotide transmembrane transporter activity (GO:0000295),1/12,0.10229426679107169,0.2158582409404818,0,0,10.117466802860061,23.06682926467287,SLC25A5
single-stranded telomeric DNA binding (GO:0043047),1/12,0.10229426679107169,0.2158582409404818,0,0,10.117466802860061,23.06682926467287,HNRNPA2B1
cAMP binding (GO:0030552),1/12,0.10229426679107169,0.2158582409404818,0,0,10.117466802860061,23.06682926467287,PDE4B
histone demethylase activity (H3-K9 specific) (GO:0032454),1/13,0.11033354351936198,0.22335814907578155,0,0,9.273876404494382,20.441916907043897,JMJD1C
insulin-like growth factor I binding (GO:0031994),1/13,0.11033354351936198,0.22335814907578155,0,0,9.273876404494382,20.441916907043897,INSR
titin binding (GO:0031432),1/13,0.11033354351936198,0.22335814907578155,0,0,9.273876404494382,20.441916907043897,CALM1
protein phosphatase activator activity (GO:0072542),1/13,0.11033354351936198,0.22335814907578155,0,0,9.273876404494382,20.441916907043897,CALM1
GDP-dissociation inhibitor activity (GO:0005092),1/13,0.11033354351936198,0.22335814907578155,0,0,9.273876404494382,20.441916907043897,GDI2
U6 snRNA binding (GO:0017070),1/14,0.11830122462385118,0.23378575342332494,0,0,8.560069144338808,18.27164868713807,PRPF8
deoxyribonuclease activity (GO:0004536),1/14,0.11830122462385118,0.23378575342332494,0,0,8.560069144338808,18.27164868713807,RPS3
phosphatase activator activity (GO:0019211),1/14,0.11830122462385118,0.23378575342332494,0,0,8.560069144338808,18.27164868713807,CALM1
insulin-like growth factor binding (GO:0005520),1/15,0.12619794408734708,0.24171760059807249,0,0,7.948234349919743,16.452079052841352,INSR
Lys48-specific deubiquitinase activity (GO:1990380),1/15,0.12619794408734708,0.24171760059807249,0,0,7.948234349919743,16.452079052841352,USP9X
muscle alpha-actinin binding (GO:0051371),1/15,0.12619794408734708,0.24171760059807249,0,0,7.948234349919743,16.452079052841352,PDLIM1
cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),1/15,0.12619794408734708,0.24171760059807249,0,0,7.948234349919743,16.452079052841352,RACK1
GTPase activity (GO:0003924),4/216,0.12916835809212074,0.24551848217509972,0,0,2.114177897574124,4.326958143258094,CDC42;DDX3X;GNAS;EEF2
histone methyltransferase activity (H3-K4 specific) (GO:0042800),1/16,0.1340243303271126,0.2509177312139176,0,0,7.417977528089888,14.908161099822989,KMT2C
"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",1/16,0.1340243303271126,0.2509177312139176,0,0,7.417977528089888,14.908161099822989,RPS3
protein tyrosine kinase binding (GO:1990782),2/72,0.13595774576553085,0.2525652668897541,0,0,3.188216303470541,6.361802310889694,HSP90AA1;RACK1
G protein-coupled receptor binding (GO:0001664),3/143,0.13693297602456547,0.2525652668897541,0,0,2.3962256493506495,4.764328473126039,HSPA8;GRK2;GNAS
calcium-release channel activity (GO:0015278),1/17,0.14178100627369258,0.2544954611697984,0,0,6.954002808988764,13.584447140756783,ITPR1
peptidase activator activity involved in apoptotic process (GO:0016505),1/17,0.14178100627369258,0.2544954611697984,0,0,6.954002808988764,13.584447140756783,RACK1
glutamate receptor binding (GO:0035254),1/17,0.14178100627369258,0.2544954611697984,0,0,6.954002808988764,13.584447140756783,GNAS
protein tyrosine phosphatase activity (GO:0004725),2/74,0.14206774740000794,0.2544954611697984,0,0,3.099340866290019,6.0482125791464725,PTPRE;PTPRK
cadherin binding involved in cell-cell adhesion (GO:0098641),1/18,0.1494685893137094,0.2658405624222403,0,0,6.544613350958361,12.439143799224476,PDLIM1
ligand-gated calcium channel activity (GO:0099604),1/19,0.15708769147064042,0.2754565857478131,0,0,6.180711610486892,11.440194862508468,ITPR1
anion:anion antiporter activity (GO:0015301),1/19,0.15708769147064042,0.2754565857478131,0,0,6.180711610486892,11.440194862508468,SLC25A5
transcription coactivator binding (GO:0001223),1/20,0.1646389193089532,0.280788293889927,0,0,5.855115316380839,10.56263137333112,RPL23
microtubule plus-end binding (GO:0051010),1/20,0.1646389193089532,0.280788293889927,0,0,5.855115316380839,10.56263137333112,NUMA1
ubiquitin-like protein-specific protease activity (GO:0019783),1/20,0.1646389193089532,0.280788293889927,0,0,5.855115316380839,10.56263137333112,USP9X
endodeoxyribonuclease activity (GO:0004520),1/20,0.1646389193089532,0.280788293889927,0,0,5.855115316380839,10.56263137333112,RPS3
"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",1/21,0.17212287411312943,0.2876415815716055,0,0,5.562078651685393,9.786736985653446,PDE4B
acetylation-dependent protein binding (GO:0140033),1/21,0.17212287411312943,0.2876415815716055,0,0,5.562078651685393,9.786736985653446,BAZ2A
lysine-acetylated histone binding (GO:0070577),1/21,0.17212287411312943,0.2876415815716055,0,0,5.562078651685393,9.786736985653446,BAZ2A
mRNA 3'-UTR AU-rich region binding (GO:0035925),1/22,0.1795401518668945,0.2921927961755342,0,0,5.296950240770466,9.096751443014716,ZFP36L2
poly(A) binding (GO:0008143),1/22,0.1795401518668945,0.2921927961755342,0,0,5.296950240770466,9.096751443014716,DDX3X
poly(U) RNA binding (GO:0008266),1/22,0.1795401518668945,0.2921927961755342,0,0,5.296950240770466,9.096751443014716,HNRNPH1
protein kinase A regulatory subunit binding (GO:0034237),1/22,0.1795401518668945,0.2921927961755342,0,0,5.296950240770466,9.096751443014716,WASF2
GTPase activator activity (GO:0005096),5/336,0.18375128438252505,0.29267889606330943,0,0,1.6920165294996006,2.8665672834397533,EEF1B2;PREX1;AKAP13;HPS4;SH3BP5
cytokine receptor activity (GO:0004896),2/88,0.18623476184424795,0.29267889606330943,0,0,2.5929575614242544,4.358106266540562,IL7R;CD44
cyclic nucleotide binding (GO:0030551),1/23,0.18689134326934218,0.29267889606330943,0,0,5.055924412665986,8.479937399462528,PDE4B
cyclic-nucleotide phosphodiesterase activity (GO:0004112),1/23,0.18689134326934218,0.29267889606330943,0,0,5.055924412665986,8.479937399462528,PDE4B
DNA replication origin binding (GO:0003688),1/23,0.18689134326934218,0.29267889606330943,0,0,5.055924412665986,8.479937399462528,HSPD1
gamma-tubulin binding (GO:0043015),1/23,0.18689134326934218,0.29267889606330943,0,0,5.055924412665986,8.479937399462528,DDX3X
alpha-actinin binding (GO:0051393),1/24,0.19417703385256926,0.3003110647781972,0,0,4.835857352222765,7.925897616026212,PDLIM1
lipoprotein particle binding (GO:0071813),1/24,0.19417703385256926,0.3003110647781972,0,0,4.835857352222765,7.925897616026212,HSPD1
phosphatidylinositol binding (GO:0035091),2/92,0.19919558816513286,0.3055199988503844,0,0,2.4772128060263654,3.9969037944545462,NUMA1;ITPR1
NF-kappaB binding (GO:0051059),1/25,0.2013978039759471,0.3055199988503844,0,0,4.634129213483146,7.426067881764699,NPM1
poly-pyrimidine tract binding (GO:0008187),1/25,0.2013978039759471,0.3055199988503844,0,0,4.634129213483146,7.426067881764699,HNRNPH1
histone deacetylase binding (GO:0042826),2/93,0.2024530112863993,0.3055199988503844,0,0,2.449866517663128,3.9130430785361145,HSP90AA1;HSP90AB1
protein homodimerization activity (GO:0042803),8/636,0.2112821434930138,0.3169232152395207,0,0,1.4298059373486796,2.222720355852111,HSP90AA1;NPM1;CENPF;HSP90AB1;HPS4;RACK1;PECAM1;MYH9
androgen receptor binding (GO:0050681),1/27,0.21564687880438416,0.3196194810850694,0,0,4.277225583405358,6.561747497292318,DDX5
metal ion transmembrane transporter activity (GO:0046873),1/27,0.21564687880438416,0.3196194810850694,0,0,4.277225583405358,6.561747497292318,ITPR1
histone demethylase activity (GO:0032452),1/28,0.22267631886123884,0.32424797307864606,0,0,4.118601747815231,6.186288287936283,JMJD1C
thyroid hormone receptor binding (GO:0046966),1/28,0.22267631886123884,0.32424797307864606,0,0,4.118601747815231,6.186288287936283,JMJD1C
poly-purine tract binding (GO:0070717),1/28,0.22267631886123884,0.32424797307864606,0,0,4.118601747815231,6.186288287936283,DDX3X
snoRNA binding (GO:0030515),1/30,0.23654780520486846,0.34046476009255633,0,0,3.8341728012398297,5.52736250975957,PRKDC
miRNA binding (GO:0035198),1/30,0.23654780520486846,0.34046476009255633,0,0,3.8341728012398297,5.52736250975957,HNRNPA2B1
Hsp70 protein binding (GO:0030544),1/31,0.24339095709228417,0.3463105618055929,0,0,3.7061797752808987,5.23715168631318,RPS3
kinase activator activity (GO:0019209),1/31,0.24339095709228417,0.3463105618055929,0,0,3.7061797752808987,5.23715168631318,RPLP1
thiol-dependent deubiquitinase (GO:0004843),2/106,0.24522919478840335,0.3469435767176843,0,0,2.142220773576706,3.0110241509440856,USP9X;TNFAIP3
histone methyltransferase activity (GO:0042054),1/32,0.25017311042990215,0.3499612612193575,0,0,3.5864443638999637,4.969385053851574,KMT2C
neutral amino acid transmembrane transporter activity (GO:0015175),1/32,0.25017311042990215,0.3499612612193575,0,0,3.5864443638999637,4.969385053851574,SLC38A1
telomeric DNA binding (GO:0042162),1/33,0.2568948059086201,0.3573564618505386,0,0,3.474192415730337,4.721735283530793,HNRNPA2B1
deubiquitinase activity (GO:0101005),2/112,0.2651171091781443,0.36559555217312434,0,0,2.0247560349255265,2.6880329650656627,USP9X;TNFAIP3
omega peptidase activity (GO:0008242),2/113,0.26843370540780126,0.36559555217312434,0,0,2.006413192853871,2.6387369244432604,USP9X;TNFAIP3
GTPase binding (GO:0051020),3/201,0.26856412429205134,0.36559555217312434,0,0,1.6893078512396693,2.220874868088187,AKAP13;HSP90AA1;HPS4
Hsp90 protein binding (GO:0051879),1/35,0.2701589622484132,0.36559555217312434,0,0,3.2694976867151353,4.278937913532702,RPS3
ubiquitin-like protein conjugating enzyme binding (GO:0044390),1/35,0.2701589622484132,0.36559555217312434,0,0,3.2694976867151353,4.278937913532702,RPS3
regulatory RNA binding (GO:0061980),1/40,0.30229828207251697,0.40687714722192825,0,0,2.8496110630942093,3.409106720007189,HNRNPA2B1
E-box binding (GO:0070888),1/41,0.3085552164816514,0.4130658543222107,0,0,2.778230337078652,3.266794554762887,TCF4
cell-cell adhesion mediator activity (GO:0098632),1/42,0.3147563498033621,0.41911407005902224,0,0,2.7103315976979996,3.133025243602289,PDLIM1
snRNA binding (GO:0017069),1/43,0.3209021768800045,0.42502469171872936,0,0,2.645666131621188,3.0071142532146395,PRPF8
damaged DNA binding (GO:0003684),1/44,0.3269931882781703,0.4308005496363196,0,0,2.584008361640972,2.888445733811662,RPS3
histone-lysine N-methyltransferase activity (GO:0018024),1/45,0.333029870096283,0.431898112781117,0,0,2.5251532175689477,2.7764642761703553,KMT2C
single-stranded RNA binding (GO:0003727),1/45,0.333029870096283,0.431898112781117,0,0,2.5251532175689477,2.7764642761703553,DDX3X
protein kinase C binding (GO:0005080),1/45,0.333029870096283,0.431898112781117,0,0,2.5251532175689477,2.7764642761703553,RACK1
microtubule binding (GO:0008017),3/232,0.34418756467258027,0.44405545908534966,0,0,1.4583167923779277,1.5553947888587076,MACF1;NUMA1;RPS3
"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",4/333,0.3482839340043445,0.4470242245725865,0,0,1.3541988710377768,1.4283239655166502,NR4A1;IRF4;TCF4;MDM4
cation transmembrane transporter activity (GO:0008324),1/48,0.35081873612179865,0.44796853997091207,0,0,2.3636146306478603,2.4758523136927773,SLC38A1
amino acid transmembrane transporter activity (GO:0015171),1/49,0.35664287649387955,0.45308202166824496,0,0,2.314255617977528,2.386044622976128,SLC38A1
endonuclease activity (GO:0004519),1/51,0.36813573176503045,0.46530861527661205,0,0,2.2214606741573033,2.2199135878505025,RPS3
calcium ion binding (GO:0005509),4/348,0.3787415448187497,0.47238338565300364,0,0,1.2941528239202658,1.2564945896709634,GSN;ITPR1;CALM1;TPT1
L-amino acid transmembrane transporter activity (GO:0015179),1/53,0.37942440614699086,0.47238338565300364,0,0,2.1358038029386344,2.0698072417592632,SLC38A1
transcription coregulator binding (GO:0001221),1/53,0.37942440614699086,0.47238338565300364,0,0,2.1358038029386344,2.0698072417592632,RPL23
pyrophosphatase activity (GO:0016462),1/54,0.3849933053088833,0.476932005084139,0,0,2.0953996184015264,2.0001204014908907,DDX3X
calcium ion transmembrane transporter activity (GO:0015085),1/55,0.39051250711969415,0.48137432808318736,0,0,2.0564918851435707,1.93370961653662,ITPR1
myosin binding (GO:0017022),1/56,0.39598245251515657,0.48333152292291176,0,0,2.0189989785495404,1.8703711370532194,GSN
receptor tyrosine kinase binding (GO:0030971),1/56,0.39598245251515657,0.48333152292291176,0,0,2.0189989785495404,1.8703711370532194,RACK1
carboxylic acid transmembrane transporter activity (GO:0046943),1/57,0.4014035787249117,0.48519170438108256,0,0,1.9828451043338684,1.8099170724500997,SLC38A1
protein phosphatase regulator activity (GO:0019888),1/57,0.4014035787249117,0.48519170438108256,0,0,1.9828451043338684,1.8099170724500997,CALM1
transmembrane receptor protein kinase activity (GO:0019199),1/60,0.4173783556062544,0.49965005070171803,0,0,1.8817368120358027,1.6441903856137925,INSR
transmembrane receptor protein tyrosine kinase activity (GO:0004714),1/60,0.4173783556062544,0.49965005070171803,0,0,1.8817368120358027,1.6441903856137925,INSR
SH3 domain binding (GO:0017124),1/62,0.42779195299298617,0.5096660109820744,0,0,1.8198563271320685,1.5452732974879233,WASF2
motor activity (GO:0003774),1/66,0.44806709437486814,0.5312795547587722,0,0,1.7075194468452894,1.370817603404935,MYH9
sequence-specific double-stranded DNA binding (GO:1990837),7/712,0.45459884396844213,0.5364697258205787,0,0,1.1035131123206334,0.8699434282368532,NR4A1;IRF4;ARID5B;TCF4;SMARCA2;BACH2;HSPD1
small GTPase binding (GO:0031267),2/175,0.4657346764626449,0.5456246520418392,0,0,1.2833023088729956,0.9806215622131984,AKAP13;HPS4
ubiquitin-protein transferase activity (GO:0004842),4/392,0.46673916018036843,0.5456246520418392,0,0,1.1448011782032401,0.8723210062222814,CDC42;RNF213;HUWE1;TNFAIP3
ubiquitin binding (GO:0043130),1/74,0.48649879492275916,0.5660663548400329,0,0,1.5197783592427274,1.0950320018904065,TNFAIP3
"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",1/75,0.49111168791416604,0.5687758618168713,0,0,1.499164895232311,1.0660317307484233,GSN
protein heterodimerization activity (GO:0046982),2/188,0.5032902516112536,0.5801818178296395,0,0,1.1928193912885001,0.8189757597392083,NR4A1;TCF4
GTP binding (GO:0005525),2/189,0.5061085743090257,0.580742096787776,0,0,1.1863802531798544,0.8079297679080977,CDC42;INSR
RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),2/190,0.5089165739721564,0.5812854445828758,0,0,1.1800096165404497,0.7970624853675792,NPM1;BAZ2A
amyloid-beta binding (GO:0001540),1/80,0.5135652867259022,0.5839166958664368,0,0,1.4039254729057034,0.9355452131008957,INSR
tubulin binding (GO:0015631),3/307,0.5201758880733748,0.5887445278648651,0,0,1.0943293959330143,0.7152408657854181,DDX3X;NUMA1;RPS3
double-stranded DNA binding (GO:0003690),6/651,0.5289136196014289,0.5959252999129222,0,0,1.0311063314961688,0.656742710834844,NR4A1;PRKDC;IRF4;RPS3;TCF4;BACH2
DNA-binding transcription factor binding (GO:0140297),2/208,0.5576549085120062,0.6254778027904935,0,0,1.0759146508693982,0.6283502425840641,NPM1;YWHAZ
transcription regulatory region nucleic acid binding (GO:0001067),2/212,0.568011888001774,0.6342374892934607,0,0,1.0552058111380145,0.5968380515398704,ARID5B;SMARCA2
phosphatidylinositol bisphosphate binding (GO:1902936),1/94,0.5713289936848839,0.6342581742808693,0,0,1.1917361362812613,0.6671220482050944,GSN
guanyl ribonucleotide binding (GO:0032561),2/214,0.5731248562778939,0.6342581742808693,0,0,1.045144440891163,0.5817814159096835,CDC42;INSR
zinc ion binding (GO:0008270),3/336,0.5813314719619515,0.6392718750610911,0,0,0.9975429975429976,0.5411014030103806,RPS27;RPS29;MDM4
single-stranded DNA binding (GO:0003697),1/97,0.5827900226460548,0.6392718750610911,0,0,1.1543188202247192,0.6232494265372677,HSPD1
cysteine-type peptidase activity (GO:0008234),1/98,0.5865422389024972,0.6405658661698325,0,0,1.14236070890768,0.609461541391426,USP9X
cysteine-type endopeptidase activity (GO:0004197),1/105,0.6118846266505551,0.6653243320348831,0,0,1.0650929127052722,0.5231859222100053,USP9X
protein tyrosine kinase activity (GO:0004713),1/108,0.6222670340338835,0.6736717020627695,0,0,1.0350729812034023,0.4910240931759897,INSR
kinase activity (GO:0016301),1/112,0.6356818232848254,0.6852154718524741,0,0,0.9975706043121774,0.45195646366632986,PGK1
phosphatase binding (GO:0019902),1/114,0.6422104709159115,0.6892689968019913,0,0,0.9798150541911107,0.4339005075944154,RACK1
protease binding (GO:0002020),1/118,0.6549207688968499,0.6998938689069341,0,0,0.9461250360126765,0.40043891978292484,TNFAIP3
metallopeptidase activity (GO:0008237),1/121,0.6641579003214862,0.7067321247010687,0,0,0.9223314606741573,0.3774506437392849,PRPF8
protein phosphatase binding (GO:0019903),1/123,0.6701789614701605,0.7101045166215744,0,0,0.9071191748019893,0.3630386145084013,RACK1
metal ion binding (GO:0046872),4/517,0.6833158691186646,0.7194007307070142,0,0,0.8602840434419382,0.3275944889689927,GSN;ITPR1;CALM1;TPT1
ubiquitin protein ligase activity (GO:0061630),2/263,0.684730815974146,0.7194007307070142,0,0,0.8468082343009287,0.3207112484465108,CDC42;HUWE1
ubiquitin-like protein ligase activity (GO:0061659),2/270,0.698573326758542,0.7308603292557856,0,0,0.8243949742811367,0.2957229489946545,CDC42;HUWE1
organic anion transmembrane transporter activity (GO:0008514),1/144,0.727269178195256,0.7550244940022401,0,0,0.7730808517325372,0.2461942543199985,SLC38A1
transcription cis-regulatory region binding (GO:0000976),4/549,0.7277344520503519,0.7550244940022401,0,0,0.8084298820445609,0.25693442599169974,NPM1;RPS3;ARID5B;SMARCA2
transition metal ion binding (GO:0046914),3/445,0.7639562993325754,0.789315844538636,0,0,0.7473390580008227,0.20121707395146846,RPS27;RPS29;MDM4
protein serine/threonine kinase activity (GO:0004674),2/344,0.8161751041554121,0.839783474936767,0,0,0.6435722073545446,0.1307264789845126,GRK2;PRKDC
GTPase regulator activity (GO:0030695),1/233,0.8784010541140043,0.8993680651672145,0,0,0.4743558698179,0.06150119111807334,PREX1
sequence-specific DNA binding (GO:0043565),4/707,0.8813084654650616,0.8993680651672145,0,0,0.6215972363340785,0.07853730857574097,NR4A1;IRF4;TCF4;BACH2
G protein-coupled receptor activity (GO:0004930),1/283,0.9228823052323164,0.937949771440191,0,0,0.3892541238345685,0.031239031479352267,GPR176
endopeptidase activity (GO:0004175),1/315,0.9424143387349345,0.9539071965243849,0,0,0.3490123810205396,0.020700011946388326,USP9X
RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),5/1149,0.978916304136428,0.9828635472982686,0,0,0.46913933767382043,0.009996951737225299,NR4A1;IRF4;KLF9;TCF4;BACH2
cis-regulatory region sequence-specific DNA binding (GO:0000987),5/1149,0.978916304136428,0.9828635472982686,0,0,0.46913933767382043,0.009996951737225299,NR4A1;IRF4;KLF9;TCF4;BACH2
RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),6/1359,0.9847150050463451,0.9847150050463451,0,0,0.4733988695641029,0.007291769724996967,NR4A1;IRF4;KLF9;RPS3;TCF4;BACH2
